Evidence map›Paper›PMID 39206114›Full record

ArticleFrontiers in neuroscience2024

Mining Alzheimer's disease clinical data: reducing effects of natural aging for predicting progression and identifying subtypes.

Tian Han, Yunhua Peng, Ying Du, Yunbo Li, Ying Wang, Wentong Sun, Lanxin Cui, Qinke Peng

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tian HanSystems Engineering Institute, School of Automation, Xi'an Jiaotong University, Xi'an, China.
Yunhua PengCenter for Mitochondrial Biology and Medicine, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, China.
Ying DuDepartment of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
Yunbo LiDepartment of Nuclear Medicine, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
Ying WangSystems Engineering Institute, School of Automation, Xi'an Jiaotong University, Xi'an, China.
Wentong SunSystems Engineering Institute, School of Automation, Xi'an Jiaotong University, Xi'an, China.
Lanxin CuiSystems Engineering Institute, School of Automation, Xi'an Jiaotong University, Xi'an, China.
Qinke PengSystems Engineering Institute, School of Automation, Xi'an Jiaotong University, Xi'an, China.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
NIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

Introduction: Because Alzheimer's disease (AD) has significant heterogeneity in encephalatrophy and clinical manifestations, AD research faces two critical challenges: eliminating the impact of natural aging and extracting valuable clinical data for patients with AD. Methods: This study attempted to address these challenges by developing a novel machine-learning model called tensorized contrastive principal component analysis (T-cPCA). The objectives of this study were to predict AD progression and identify clinical subtypes while minimizing the influence of natural aging. Results: We leveraged a clinical variable space of 872 features, including almost all AD clinical examinations, which is the most comprehensive AD feature description in current research. T-cPCA yielded the highest accuracy in predicting AD progression by effectively minimizing the confounding effects of natural aging. Discussion: The representative features and pathogenic circuits of the four primary AD clinical subtypes were discovered. Confirmed by clinical doctors in Tangdu Hospital, the plaques (18F-AV45) distribution of typical patients in the four clinical subtypes are consistent with representative brain regions found in four AD subtypes, which further offers novel insights into the underlying mechanisms of AD pathogenesis.

Indexed as

AD progression predictionAD subtype identificationnatural agingT-cPCAtime-series analysis

Identifiers

PMID39206114
PMCPMC11351280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.